Market Overview

Why Cantor Fitzgerald Is No Longer An Aurora Cannabis Bull

Why Cantor Fitzgerald Is No Longer An Aurora Cannabis Bull

Contrary to expectations, Aurora Cannabis Inc (NYSE: ACB) has used what was remaining of its $183-million equity facility over the last 30 days, according to Cantor Fitzgerald.

The Aurora Cannabis Analyst: Pablo Zuanic downgraded Aurora Cannabis from Overweight to Neutral and reduced the price target from CA$18 ($13.68) to CA$7 ($5.32).

The Aurora Cannabis Thesis: For Aurora, “a slew of bad news over the past few months” has exerted downward pressure on the stock, Zuanic said in a Tuesday downgrade note. 

Even after the stock derating, there are no medium-term catalysts to lend upside, the analyst said. 

"We had decided to stay OW on overall market tailwinds (Canada rec market accelerating) and on the expected portfolio adjustments (a “pivot”) under new CEO Martin."

Yet the equity facility being used and Aurora's plans for more security filings indicate further dilution, he said. 

Write-offs; dependence on the competitive "value end" of cannabis flower; the time needed for a portfolio pivot; Nelson Peltz's exit; the "somewhat unexpected" full usage of an equity facility; and a $500-million base shelf prospectus filing Tuesday are all drivers behind Cantor's downgrade, Zuanic said. 

The analyst recommends Aphria Inc (NASDAQ: APHA) to those seeking Canada exposure.

ACB Price Action: Aurora shares were down 7.16% at $4.08 at last check Tuesday. 

Photo courtesy of Aurora Cannabis. 

Latest Ratings for ACB

Nov 2020JefferiesDowngradesHoldUnderperform
Nov 2020StifelDowngradesHoldSell
Nov 2020Cantor FitzgeraldMaintainsNeutral

View More Analyst Ratings for ACB
View the Latest Analyst Ratings


Related Articles (ACB)

View Comments and Join the Discussion!

Posted-In: Analyst Color Cannabis Penny Stocks Downgrades Price Target Markets Analyst Ratings Movers Best of Benzinga

Cannabis Movers